[Combination of betablocking-vasodilator and diuretic agents in the treatment of arterial hypertension. Changes in Hemodynamics and plasma-renin levels].
作者信息
Fernández-Andrade C, Herrera Carranza M, Villalobos Galán E, Mateos Aguilar J, Quereda C, Navarro R, Martinez Martin A, Mendoza Llera M
出版信息
Rev Clin Esp. 1978 Mar 15;148(5):491-6.
PMID:27844
Abstract
摘要
相似文献
1
2
3
[The potential of beta-blockaders in the management of hypertension].[β受体阻滞剂在高血压治疗中的潜力]
Internist (Berl). 1978 Sep;19(9):510-9.
4
Antihypertensive efficacy of a new long acting hydralazine like vasodilator, ISF 2469 in combination with a betablocker and a diuretic.一种新型长效肼屈嗪类血管扩张剂ISF 2469与β受体阻滞剂及利尿剂联合使用的降压疗效。
Int J Clin Pharmacol Biopharm. 1979 Oct;17(10):380-5.
5
Beta-adrenergic blockade in diuretic-treated patients with essential hypertension.利尿剂治疗的原发性高血压患者中的β-肾上腺素能阻滞剂
N Engl J Med. 1975 Jan 9;292(2):66-70. doi: 10.1056/NEJM197501092920203.
6
[Essential hypertension: Renin and aldosterone, key to pathogeny and therapy?].[原发性高血压：肾素与醛固酮，发病机制及治疗的关键？]
Schweiz Med Wochenschr. 1974 Jul 20;104(29):1013-22.
7
Modern concepts in the drug treatment of arterial hypertension.动脉高血压药物治疗的现代理念。
Int J Clin Pharmacol Ther Toxicol. 1980 Sep;18(9):412-9.
8
Practical clinical pharmacology of antihypertensive drugs.抗高血压药物的实用临床药理学
Cardiovasc Clin. 1975;7(1):143-56.
9
[Physiopathological approach to the therapy of arterial hypertension in diabetic nephropathy].[糖尿病肾病动脉高血压治疗的病理生理学方法]
Minerva Nefrol. 1982 Jul-Sep;29(3 Suppl):37-44.
10
Zotero 插件